Aldosterone action in the heart

被引:7
作者
Firsov, D [1 ]
Muller, OG [1 ]
机构
[1] Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland
来源
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 2003年 / 446卷 / 03期
关键词
D O I
10.1007/s00424-003-1049-4
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
引用
收藏
页码:328 / 333
页数:6
相关论文
共 79 条
[1]  
Andren B, 1996, EUR HEART J, V17, P1800
[2]   CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR [J].
ARRIZA, JL ;
WEINBERGER, C ;
CERELLI, G ;
GLASER, TM ;
HANDELIN, BL ;
HOUSMAN, DE ;
EVANS, RM .
SCIENCE, 1987, 237 (4812) :268-275
[3]   Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes [J].
Beggah, AT ;
Escoubet, B ;
Puttini, S ;
Cailmail, S ;
Delage, V ;
Ouvrard-Pascaud, A ;
Bocchi, B ;
Peuchmaur, M ;
Delcayre, C ;
Farman, N ;
Jaisser, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :7160-7165
[4]   Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats [J].
Benetos, A ;
Lacolley, P ;
Safar, ME .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (06) :1152-1156
[5]   Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes [J].
Bénitah, JP ;
Perrier, E ;
Gómez, AM ;
Vassort, G .
JOURNAL OF PHYSIOLOGY-LONDON, 2001, 537 (01) :151-160
[6]  
Bénitah JP, 1999, CIRC RES, V85, P1139
[7]   ANTI-ALDOSTERONE TREATMENT AND THE PREVENTION OF MYOCARDIAL FIBROSIS IN PRIMARY AND SECONDARY HYPERALDOSTERONISM [J].
BRILLA, CG ;
MATSUBARA, LS ;
WEBER, KT .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1993, 25 (05) :563-575
[8]   ANTIFIBROTIC EFFECTS OF SPIRONOLACTONE IN PREVENTING MYOCARDIAL FIBROSIS IN SYSTEMIC ARTERIAL-HYPERTENSION [J].
BRILLA, CG ;
MATSUBARA, LS ;
WEBER, KT .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (03) :A12-A16
[9]  
BRILLA CG, 1992, J LAB CLIN MED, V120, P893
[10]   The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. [J].
Brown, RW ;
Diaz, R ;
Robson, AC ;
Kotelevtsev, YV ;
Mullins, JJ ;
Kaufman, MH ;
Seckl, JR .
ENDOCRINOLOGY, 1996, 137 (02) :794-797